For research use only
| Cat No. | ABC-SC0230 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Friedreich Ataxia 1 |
| Storage | Liquid Nitrogen |
Heritable Diseases Disorders of the Nervous System, Trinucleotide Expansions
HighQC™ Human Induced Pluripotent Stem Cells, From Friedreich Ataxia 1 are derived from patients with Friedreich Ataxia (FRDA). These cells are generated using a retroviral vector to deliver the transcription factors OCT4, SOX2, KLF4, and c-MYC. Donor cells are clinically affected by ataxia, cardiomyopathy, and mild peripheral neuropathy, and are homozygous for the GAA trinucleotide repeat expansion in the FXN gene in the frataxin gene with alleles of approximately 541 and 420 repeats. These cells was evaluated for viability surface antigen expression and alkaline phosphatase activity. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human Induced Pluripotent Stem Cells, From Friedreich Ataxia 1, Human iPSC-FA1, hIPSC-FA1, Human Induced Pluripotent Stem Cells Friedreich Ataxia |
| Species | Human |
| Cat.No | ABC-SC0230 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Friedreich Ataxia 1 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human Induced Pluripotent Stem Cells, From Friedreich Ataxia 1 provide a disease-relevant in vitro research platform for investigating the molecular and cellular mechanisms of Friedreich ataxia. These cells retain the characteristic guanine-adenine-adenine trinucleotide repeat expansion in the frataxin gene, enabling genotype-phenotype correlation analyses at the cellular level. They are suitable for studying mitochondrial biology, oxidative stress regulation, iron metabolism dysregulation, and neuronal lineage-specific cellular responses under a human genetic background, serving as valuable stem cells for ataxia research and disease modeling.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).